Following on studies by Al Hajj and colleagues that demonstrated the utility of marker for CD24 (Heat stable antigen/HAS/BA-1) in isolating tumorigenic cells from breast cancers (to be discussed in detail below) [40], the Smalley laboratory then investigated the utility of CD24 in fractionating the mammary epithelium [41]. Here, CD24 is linked to breast cancer.